Raquel Milgrom
Overview
Explore the profile of Raquel Milgrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leibovitzh H, Nayeri S, Borowski K, Hernandez-Rocha C, Lee S, Turpin W, et al.
J Crohns Colitis
. 2024 Jul;
PMID: 38980940
Background: Primary sclerosing cholangitis associated with inflammatory bowel disease (IBD-PSC) carries significant morbidity compared to IBD without PSC. Alterations in microbial composition and bile acid (BA) profiles have been shown...
2.
Hernandez-Rocha C, Walshe M, Birch S, Sabic K, Korie U, Chasteau C, et al.
J Crohns Colitis
. 2023 Nov;
18(4):615-627.
PMID: 37976264
Background And Aims: Multiple factors are suggested to place Crohn's disease patients at risk of recurrence after ileocolic resection with conflicting associations. We aimed to identify clinical predictors of recurrence...
3.
Wong S, Wellens J, Helmus D, Marlow L, Brann S, Martinez Pazos V, et al.
Inflamm Bowel Dis
. 2023 Jun;
29(11):1693-1705.
PMID: 37354560
Background: Beyond systematic reviews and meta-analyses, there have been no direct studies of serological response to COVID-19 in patients with inflammatory bowel disease (IBD) across continents. In particular, there has...
4.
Dayam R, Law J, Goetgebuer R, Chao G, Abe K, Sutton M, et al.
JCI Insight
. 2022 Apr;
7(11).
PMID: 35471956
BACKGROUNDLimited information is available on the impact of immunosuppressants on COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMID).METHODSThis observational cohort study examined the immunogenicity of SARS-CoV-2 mRNA vaccines in...
5.
Zittan E, Steinhart A, Goldstein P, Milgrom R, Gralnek I, Silverberg M
Clin Transl Gastroenterol
. 2021 Oct;
12(10):e00401.
PMID: 34613952
Introduction: We investigated whether early adalimumab drug levels (ADL) at week 4 predicted biological remission at week 24. Methods: In a prospective study, we assessed clinical and biological remission at...
6.
Greener T, Boland K, Milgrom R, Ben-Bassat O, Steinhart A, Silverberg M, et al.
Eur J Gastroenterol Hepatol
. 2021 Aug;
33(10):1274-1279.
PMID: 34402466
Background: Many Crohn's disease patients treated with anti-tumor necrosis factor (TNF) therapies suffer from loss of response over time and require dose escalation. The aim of this study was to...
7.
Zittan E, Muir J, Milgrom R, Berns M, Gralnek I, Cohen Z, et al.
Int J Surg
. 2019 Mar;
65:80-85.
PMID: 30926567
Background: We sought to determine whether preoperative exposure to anti-TNF therapy affects objective histological measures of fibrosis in the colorectum. Methods: Ulcerative colitis (UC) patients who received infliximab as maintenance...
8.
ODonnell S, Borowski K, Espin-Garcia O, Milgrom R, Kabakchiev B, Stempak J, et al.
Inflamm Bowel Dis
. 2019 Feb;
25(9):1541-1549.
PMID: 30801121
Background: While progress has been made in the identification of Crohn's disease (CD) susceptibility loci, efforts to identify a genetic basis for disease progression have been less fruitful. The specific...
9.
Zittan E, Kabakchiev B, Kelly O, Milgrom R, Nguyen G, Croitoru K, et al.
J Crohns Colitis
. 2017 Apr;
11(5):543-548.
PMID: 28453763
Background: There is a need for better, less-invasive disease activity indices that provide a representative assessment of endoscopic disease activity. We developed a new clinical score that incorporates the Harvey-Bradshaw...
10.
Fortinsky K, Kevans D, Qiang J, Xu W, Bellolio F, Steinhart H, et al.
Dig Dis Sci
. 2016 Oct;
62(1):188-196.
PMID: 27778204
Background And Aims: The utility of postoperative medical prophylaxis (POMP) and the treatment of mild endoscopic recurrence remain controversial. Methods: This study is a retrospective review of patients undergoing a...